Background Malignant pleural effusions (MPE) are a frequent cause of dyspnea and
discomfort at the end of cancer patients' lives. The tunneled indwelling pleural catheter …

Palliative care is a philosophy aimed at enhancing quality of life through the effective
management of pain and distressing symptoms while incorporating psychosocial and …

BACKGROUND: A malignant pleural effusion (MPE) is a late complication of malignancy
that affects respiratory function and quality of life. A strategy for palliation of the symptoms …

Epidermal growth factor receptor (EGFR)‐tyrosine kinase inhibitors (TKIs), including
gefitinib, are the first‐line treatment of choice for nonsmall cell lung cancer patients who …

Background The in vitro stability assessment is essential for investigating the diagnostic
accuracy of pleural biomarkers. This study aimed to investigate the long‐term stability of …

Background Pleural effusion (PE) can be divided into benign pleural effusion (BPE) and
malignant pleural effusion (MPE). There is no consensus on the identification of lung cancer …

Helicobacter pylori neutrophil-activating protein (NAP) is a major virulence factor and
powerful inducer of inflammatory reaction and Th1-polarized immune response. Here, we …

Background To evaluate the diagnostic value of combinations of tumor markers
carcinoembryonic antigen (CEA), carbohydrate antigen (CA) 125, CA153, and CA19-9 in …

Background Pleural effusion is one of the most common complications of lung
adenocarcinoma and is diagnostically challenging. This study aimed to investigate the …

Background. The distinction between malignant and benign pleural effusions is a diagnostic
challenge today and measuring soluble biomarkers could add to the diagnostic accuracy …